Apolipoprotein E4 mRNA (APOE4 mRNA)

**APOE4 mRNA** is the messenger RNA transcribed from the APOE gene carrying the ε4 variant. This mRNA encodes the apolipoprotein E4 (**APOE4**) protein isoform, a major genetic risk factor for late-onset Alzheimer’s disease, cardiovascular diseases, and several other conditions. APOE4 mRNA is not itself a biological target for drugs in clinical use; instead, therapeutics typically address the APOE4 protein or modulate the gene’s expression. The APOE4 mRNA is studied primarily as a means to understand the regulation and synthesis of the APOE4 protein and is not itself the target of approved or advanced investigational therapies[2][3][4][1]. **Clarification:** - APOE4 mRNA is *not* a canonical therapeutic target like a receptor, enzyme, or transporter; interventions currently focus on the APOE4 protein and its effects. - The *correct* canonical target entity for most therapeutic and biological research is the **Apolipoprotein E4 protein** (encoded by the APOE ε4 allele), not “APOE4 mRNA” itself[2][3][4][1]. - If you need information on the protein target, search for "Apolipoprotein E4" or "APOE4 protein."

Other names

Apolipoprotein E4 transcriptAPOE4 transcriptAPOE ε4 mRNA

Not applicable (for mRNA; actions pertain to protein or gene modulation)